Alcon (ALC) DIvidends Date & History

Key Takeaways

• Alcon Inc. (ALC) offers a modest forward dividend yield of approximately 0.48%, paid annually.
• Low payout ratio of 17.2% indicates strong sustainability, supported by robust free cash flow (FCF, cash generated after capital expenditures) of $1.23 billion trailing twelve months.
• Dividend history shows consistent annual payments since its 2019 spin-off, with recent increases signaling commitment to shareholders.
• In the medical devices sector, ALC's yield is competitive amid peers focused on growth over high payouts.
• Upcoming ex-dividend date: May 6, 2026, with payment around early May.
• Ideal for conservative dividend investors seeking stability over high income.

Dividend Overview

Alcon Inc., a leading eye care company specializing in surgical equipment, vision care products, and pharmaceuticals, maintains a modest dividend policy. The forward annual dividend stands at $0.35 per share, delivering a yield of about 0.48% based on recent stock prices. Payments are made annually, with the next ex-dividend date set for May 6, 2026. This profile positions ALC as neither a high-yield stock nor a rapid dividend growth contender, but rather a reliable payer in a growth-oriented sector. The conservative approach allows reinvestment in innovation, such as advanced contact lenses and cataract surgery devices, while providing steady returns to shareholders.

Dividend History and Growth

Since its spin-off from Novartis in 2019, Alcon has established a track record of annual dividend payments. Recent history includes a $0.28 per share dividend declared in April 2026, payable in May, following payments of approximately $0.31 in 2025 and higher totals in prior years amid some variability. While not boasting a long dividend growth streak, ALC has shown increases, such as from earlier levels post-spin-off. This reflects a strategy prioritizing financial flexibility for R&D and acquisitions in the competitive eye care market, with consistency in distributions underscoring commitment to returning capital.

Dividend Sustainability and Payout Ratio

Alcon's dividend appears highly sustainable, underpinned by a low payout ratio of 17.2%, meaning only a fraction of earnings is distributed. Earnings comfortably cover the dividend, with trailing twelve-month operating cash flow at $2.27 billion and FCF at $1.23 billion—far exceeding dividend obligations. Moderate debt levels and strong profitability in vision care segments further bolster stability. No cuts have occurred since inception, and ample cash reserves support ongoing payments even amid market fluctuations.

Dividend Compared to Industry Peers

In the medical devices and eye care industry, Alcon's 0.48% yield is typical for growth-focused peers. For instance, CooperCompanies (COO) pays no dividend, prioritizing expansion, while Stryker (SYK) offers around 1% with steady growth. Broader healthcare equipment averages low single-digit yields, as companies like Intuitive Surgical (ISRG) forgo payouts for reinvestment. ALC's offering stands out for its coverage rather than size, appealing in a sector where dividends are secondary to innovation.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. It excels at identifying dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to streamline your research.

Is This Stock Attractive for Dividend Investors?

Alcon Inc. (ALC) suits conservative, long-term dividend investors who prioritize sustainability over high yields. Its low payout ratio and strong FCF coverage make it resilient for those building portfolios in healthcare growth names. Income seekers may find the 0.48% yield underwhelming compared to utilities or REITs, but it complements dividend growth strategies in medtech, where capital returns via buybacks often pair with modest payouts. Not ideal for yield chasers, ALC appeals to patient holders valuing stability amid eye care demand from aging populations. Balanced risk-reward favors diversified, quality-focused approaches rather than pure income plays.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations